|Placed On:||17th May 2019|
|Closes:||21st June 2019|
Start date: October 2019
The Evidence Based Procurement Board (EBPB) consists of professionals from within NHS Wales and Welsh research organisations, making recommendations and guidance for value and evidence based procurement of medical technologies for NHS Wales, whilst advising the Shared Services Committee and the Welsh Government Efficiency Healthcare Value & Improvement Group.
The Board assists with the rationalisation and standardisation agenda in line with Prudent Healthcare Principles, and is underpinned with the “Once for Wales” philosophy. It will also assess whether NHS Wales should discard devices/technologies if they are deemed inappropriate or wasteful.
Advice from EBPB is based on rapid review best practice methods. The focus is most usually based on available clinical evidence of effectiveness, safety and where available cost effectiveness evidence. Estimates of economic impact, annual budget impact and other relevant impacts (resource release, patient co-production and other qualitative impacts) for NHS Wales have not so far been incorporated into the assessment process, nor do these impacts get tracked once advice is released and are not currently part of the outputs from EBPB.
Using already released advice the MSc by Research will identify appropriate health economics frameworks and methods to enable the value of EBPB projects already completed with published advice. We anticipate two published advice reports as case studies. The research will explore the possible and impossible, establish understanding the limitations of available data, identify potential collaborations with NHS Wales Information Service (NWIS), procurement and other key NHS stakeholders to explore and identify how a pragmatic estimate of the impact and value of advice can be established. Outcomes would be evaluations of selected EBPB advice and documented methods and techniques to put in place for EBPB advice in the future.
The intended reach and location of the research is NHS Wales, working out of the Surgical Materials Testing Laboratory (SMTL), based in Bridgend, and Swansea University.
Scholarships are collaborative awards with external partners including SMEs and micro companies, as well as public and third sector organisations. The scholarship provides 1 year funding with a 3 month period to complete the thesis. The achievement of a postgraduate skills development award, PSDA, is compulsory for each KESS II scholar and is based on a 30 credit award.
Candidates should have a 2.1 or above in an undergraduate degree in economics or a closely related subject.
We would normally expect the academic and English Language requirements to be met by point of application. For details on the University’s English Language entry requirements, please visit –http://www.swansea.ac.uk/admissions/englishlanguagerequirements/
Due to funding restrictions, this scholarship is open to UK/EU candidates only.
Type / Role: